# Strateos

> Strateos integrates robotics, scientific instruments and cloud software so life-science teams can design, run and monitor experiments remotely. Its LodeStar platform supports shared cloud-lab services and private laboratory deployments, with a documented 2023 shift toward designing and deploying on-site cloud labs for biopharmaceutical customers.

- **Founded:** 2012
- **Headquarters:** Menlo Park, United States
- **Founders:** Max Hodak (Founder of predecessor Transcriptic), Todd Huffman (Founder and former CEO of predecessor 3Scan)
- **Products:** LodeStar, Robotic Cloud Laboratory / Control Our Lab, Control Your Lab, Build Your Lab, Tissue Technology
- **Notable:** Combined Transcriptic and 3Scan in June 2019., Helped launch Lilly’s remotely operated San Diego studio in January 2020., Raised a USD 56.1 million Series B in June 2021.

## Products & services

- **LodeStar** — Lab orchestration software connecting workflow design, scheduling, scientific instruments, sample information and experimental data. Publicly documented by 2023; launch year unverified.
- **Robotic Cloud Laboratory / Control Our Lab** — Remote browser-based access to automated life-science workflows; the company describes biology, medicinal chemistry and synthetic biology capabilities.
- **Control Your Lab** — Modular software for managing and automating a customer’s on-premises research equipment and workflows.
- **Build Your Lab** — Design, integration, deployment and support for private robotic workcells and cloud-enabled research facilities.
- **Tissue Technology** — Historically advertised early-access automated tissue sectioning, imaging and web-based visualization; current availability requires confirmation.

## Achievements

- Combined Transcriptic and 3Scan in June 2019.
- Helped launch Lilly’s remotely operated San Diego studio in January 2020.
- Raised a USD 56.1 million Series B in June 2021.
- Reported five integrated automated protocols in a University of Wisconsin protein-engineering case study.
- Reported completion of multimillion-dollar design programs for two top-20 biopharmaceutical companies in April 2023.

## Latest updates

- **2023-04** — Announced a strategic shift toward on-site cloud-lab design and deployment, alongside a staffing reorganization and completed multimillion-dollar design programs.
- **2024-11** — The company homepage promoted a Cloud Lab, HTE & Lab Automation virtual conference scheduled for November 5-6, 2024; this records an event advertisement, not confirmation of attendance or delivery.

## Links

- Website: https://strateos.com/
- LinkedIn: https://www.linkedin.com/company/strateos1/
- Twitter/X: https://x.com/strateoslab
- GitHub: https://github.com/strateos
- YouTube: https://www.youtube.com/@strateos2034
- Facebook: https://www.facebook.com/StrateosLab/

---

Profile page: https://yespress.io/strateos
Published by YesPress — https://yespress.io
Last updated: 2026-09-30